US 12152034
FGFR inhibitors and methods of making and using the same
granted A61PA61P35/00
Quick answer
US patent 12152034 (FGFR inhibitors and methods of making and using the same) held by Relay Therapeutics, Inc. expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Relay Therapeutics, Inc.
- Grant date
- Tue Nov 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P35/00